期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | World Journal of Clinical Cases LetPub Score 5.5
54 ratings
Rate
Reputation 6.3 Influence 3.8 Speed 9.3 | ||||||||||||||||
期刊簡稱 | WORLD J CLIN CASES | ||||||||||||||||
ISSN | 2307-8960 | ||||||||||||||||
h-index | N.A. | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 10.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.wjgnet.com/2307-8960 | ||||||||||||||||
在線稿件提交 | https://www.f6publishing.com/Forms/Main/Login.aspx | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Baishideng Publishing Group | ||||||||||||||||
主題領域 | Medicine | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 0 | ||||||||||||||||
每年文章數 | 981每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 97.14% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2307-8960%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[World Journal of Clinical Cases] 的評論 | 撰寫評論 |
作者: 九阴素玲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-27 12:03:09 評論於 This is me(0) 讚! | 九阴素玲 |
作者: 九阴素玲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-21 18:27:20 評論於 Click on my profile picture to see the homepage and communicate(0) 讚! | 九阴素玲 |
作者: 仲夏寄灵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-20 23:01:53 評論於 Are there any senior brothers in the group?(0) 讚! | 仲夏寄灵 |
作者: 仲夏寄灵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-20 13:48:11 評論於 Please translate the following passage into English and Japanese(0) 讚! | 仲夏寄灵 |
作者: 九阴素玲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-05 12:09:02 評論於 If you have any questions, we can discuss them. This magazine "baishideng" is quite good(0) 讚! | 九阴素玲 |
作者: 一条小华采 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-04 14:01:52 評論於 The editor said he couldn't find any reviewers for the submission after 5 months of waiting. It's really frustrating to have to withdraw the submission(0) 讚! | 一条小华采 |
作者: 伯克阿诺德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-16 19:15:40 評論於 Same question, always showing in "add reviewers"(0) 讚! | 伯克阿诺德 |
作者: 一条小宏钦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-14 15:29:34 評論於 Submission made on 3.7, currently under review. What should be the next steps?(0) 讚! | 一条小宏钦 |
作者: 一条小宏钦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-11 20:19:08 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Emphasis on research direction: Reproductive Male Experience Sharing: It has been nearly 2 months since submission, but still no response. What should I do?(0) 讚! | 一条小宏钦 |
作者: 仲夏小秋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-09 11:13:07 評論於 Experience sharing: Submitted on March 6, and on March 14, one reviewer requested major revisions. Since then, it has been in the "reviewed" status. Has anyone encountered this situation before?(0) 讚! | 仲夏小秋 |
作者: 藤原天工 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-23 18:40:43 評論於 I also submitted on January 9th and am still looking for an external review. What should I do? I'm thinking about giving up(0) 讚! | 藤原天工 |
作者: 努力啊大颖颖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-19 17:38:40 評論於 Review Speed: 1.0 | Submission Hit Rate: 50.0 Experience Sharing: I am overwhelmed. I have a submission pending for revisions, but the system was closed 10 hours in advance and I can't reach the editor. What should I do in this situation?(0) 讚! | 努力啊大颖颖 |
作者: Les Eve 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-18 17:45:15 評論於 Feel free to chat if you have any questions, efficiency is also good, the transaction is secure(0) 讚! | Les Eve |
作者: 悠柔来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-05 22:17:38 評論於 Mine too, have you got the results? The review process is really slow now(0) 讚! | 悠柔来了 |
作者: 苍风雅唱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-03 12:28:03 評論於 How many editors' emails are there? It's been three months and we're still looking for external review experts. Can't believe it(0) 讚! | 苍风雅唱 |
作者: 缠丝孤风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-26 18:07:00 評論於 Review speed: 6.0 Experience sharing(0) 讚! | 缠丝孤风 |
作者: 墟散半芹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-12 12:22:13 評論於 Research focus: Surgical experience sharing: Have you tried sharing thoracic surgery cases with colleagues?(0) 讚! | 墟散半芹 |
作者: Aubrey Ezekiel 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-16 11:09:21 評論於 Review speed: 3.0 | Submission acceptance rate: 75.0 Experience sharing: Relatively easy to get accepted, usually accepted after minor revisions(0) 讚! | Aubrey Ezekiel |
作者: Aubrey Ezekiel 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-16 09:20:11 評論於 Review speed: 3.0 | Submission acceptance rate: 75.0 Emphasis on research areas: Case studies; Pediatrics; Clinical experience sharing: Intermediate warning, quick acceptance(0) 讚! | Aubrey Ezekiel |
作者: 黄土慕波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-16 10:58:25 評論於 May I ask how to find the editor-in-chief of a magazine?(0) 讚! | 黄土慕波 |
作者: 怡畅超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-26 21:08:06 評論於 Is it still not allowed to have gatherings now?(0) 讚! | 怡畅超级甜 |
作者: 京城痴凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-09 17:09:27 評論於 How was it handled in the end?(0) 讚! | 京城痴凝 |
作者: 依山少女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-11 08:45:22 評論於 Journal Name: World Journal of Clinical Cases Impact Factor: 1.1 JCR Quartile: Q4 Chinese Academy of Sciences Quartile: Medicine 4th Area Subject Category: Medicine: Internal Medicine 4th Area OPEN ACCESS: Unclear Publication Frequency: Data not available Is it a review?: No Warning Level: Medium risk warning from the Chinese Academy of Sciences in 2023 (medium risk in 2021), with warnings from multiple locations (such as 2023 medium risk warning from Jiangsu Cancer Hospital, 2023 warning from Beijing 301 Hospital, medium risk warning from Yangtze University, and warning against submitting to Fudan University-affiliated Huashan Hospital in 2022, as well as a warning from Shanghai First People's Hospital). Units that ignore warnings are resolute in their submissions, receiving several thousand articles annually, considered relatively good, with fast processing, although the submission process is cumbersome. I submitted an article in March and received acceptance by the end of June, which does not affect graduation next year~(0) 讚! | 依山少女 |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-29 22:48:22 評論於 Review speed: 2.0 | Submission hit rate: 95.0 Research focus: Case reports; Tumor experience sharing: surprisingly, impact factor is also 1.1(0) 讚! | 是志丹吖 |
作者: 努力啊大嘉赫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-04 22:53:27 評論於 Hello, I want to ask how to proceed at the end. Do I upload by pressing the submit revised draft button?(0) 讚! | 努力啊大嘉赫 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us